Day 1, Part 5: PTAC Public Meeting | Committee Discussion | September 8, 2025 | 5/8
The Physician-Focused Payment Model Technical Advisory Committee (PTAC) held a 2-day meeting on Using Data and Health Information Technology to Transparently Empower Consumers and Support Providers.
Okay, thanks uh for returning after the
break. I'm Dr. Lee Mills, one of the
PTAC co-chairs. As you know, uh PTAC
will issue a report to the Secretary of
HHS that will describe our key findings
from this public meeting on using data
and health information technology to
transparently empower consumer and
support providers. We now have time for
the committee to reflect on our three
incredibly rich and informative sessions
today. We will hear from more experts
tomorrow, but we want to take the time
to gather our thoughts before adjourning
for the day. So, committee members, you
know the drill. Um, flip your uh your uh
name tent up when you have comments. We
do have a page of potential potential
topics for deliberation document if you
want to reference that. And please raise
your hand on Zoom. And who would like to
start?
Okay. Well, I'll jump in there then.
That going first means I have original
things to say. Um that that dwindles
over time. So I was struck um
throughout the day today as we talked so
richly about patient engagement
that
the
as someone said work to make the data
more liquid um which I just thought was
such a rich analogy. But as we do that,
the whole patient engagement
is necessary but not wholly sufficient
in and of itself to get to where we want
the health care system to go. And um you
know engagement to be effective requires
you know a principal concept of a free
market economy is that the consumer has
agency and can make choices. And it's
unfortunately true that at many many
steps in healthcare ecology patients
choice even if they had perfect
information is very limited in what they
can choose whether it's a network
whether it's a procedure whether it's uh
you know their limitations of
transportation and and social
determinant limitations all sorts of
limitations but I do wonder if in the
fullness of time you know the increase
of liquid data
will drive and spur natural explosion of
innovation and competition that will
break down those barriers and increase
agency at the end. So, so in a sense it
comes into its own over time. Um,
thought the concept of the coming of the
idea of a federated identity is really
really key and Amy spoke so eloquently
about uh breaking down portal itis. I
think that is is really a powerful
concept and um you know I heard her say
that that you know it's happening right
now all over health systems and health
plans are using federated identity
whether it's clear whether it's u IDM me
for that and I I'm very grateful to hear
that and would love to know others
experiences but at least in the region
of the country I'm familiar with I don't
know of a single health system or health
plan that's actually doing that or
talking about it now and so innovation
diffuses
Um Amy also spoke very eloquently about
the importance of the person- centered
health data apps that aggregate from
across and we saw how the fragment in
David's talk how the fragmentation is so
dramatic way larger than any one health
system or ecology and so it's really
going to require uh for true patient
empowerment and to improve agency it's
going to require a person- centered app
that can go out and gather that
information from all sources and consult
considate it in a way the patient can
use and that's really powerful. Um,
love Tom Lee's statement that there is
no best way for money to change hands in
healthcare. That was just really really
great. There's only a list of things
that we've tried that don't work. And so
that and the and the idea from um
later from Tom saying we've just simply
got the way to begin is to just do
better with the data we have and not let
perfect be in the way of the good. I
think that's just really wise and we do
have lots of data that isn't used
terribly well today and so um it just
spurs us on each and all of our own
individual venues to try to use what we
have better
and then um I enjoyed Dr. Kendrick's
comments about
you know the the about having
visibility and a view of data
completeness is a critical component of
data quality. um you know, you think
you've got what you need, but if you
only have 60% of the patients, the
patient in front of you is of their data
and it's fragmented all over, you really
never will have a view of the patient
that's real. And and being able to, you
know, quantify at the point of care what
view of the data you're seeing in your
EHR system and what is known to it is
really, really important. Um, and seems
like that ought to be a critical
component in this this idea. We've
talked about other metrics of of uh
clinical quality metrics moving towards
ECQM.
Um knowing that I'm only at, you know,
65% for this metric, but that I only
have 40% of all my patients data
contributing to that is an important
concept versus I'm at 45% and I've got
90% of the data, meaning I'm actually at
45%. So, okay, that's what I've got. Uh
I will go next to Lindsay.
>> Yeah, thanks Lee. Um maybe just one
tangible uh recommendation I heard and
then maybe a couple cautions. I think
the tangible one that just is worth
repeating is um I think just the call
out to think about how we could unlock
APIs for better access for example I
think given moving the meaningful use
requirements onto API stacks as opposed
to on the vendors themselves.
Um I think I heard a caution uh with
regards to payment um that I think is is
worth restating. So one of the concerns
around the increased use of data was
around um you know a a hesitation of
data sharing uh or restrictions on the
use of information that's provided for
uh value based care uh then being turned
and used against someone for the
purposes of payment. So when a entity
would provide the clinical information
or data for the purpose of clinical
quality improvement for example then
that information could be used against
them. And I I think as we think about um
the increased uh information we'll get
from wearables or other uh health data
from things worn by a patient 247. I
think there's real potential that that
data could be used um for adverse
determinations or other things as well.
And so I think a word a word of caution
around as we think about all the uses of
data um when it comes to payment
and I think exciting to see uh what we
will learn um
uh from the use of wearables and uh AI
to actually show improvement in
outcomes. I think the there's a lot of
data out there. Um but it will be
important I think as Ricky called out
for companies who are in this space to
show that they're not just uh
aggregating and creating bundles of data
but that it's uh improving outcomes. Um,
and so, uh, I think it'll be interesting
to see the lessons that are learned from
entities that are taking risk and
incorporating the use of wearables or
other AI tools um to see how we might
value uh, value the improvement it
provides in um, for translating to other
fee for service or other payment
methodologies.
and Krishna.
>> Yeah. From my sense, um I don't know
three things sort of stood out for me.
One is on just I think I was pleasantly
surprised hearing uh Kristen from Bwell
and Epic just the amount of patient
mediated interoperability and data
sharing like they're initiating queries
and initiating requests. Great to see
the progress uh made there. there's
obviously billions of data points. Um
that was interesting for me and then how
do we continue to sort of uh um find
ways to encourage more of that whether
it's through benefit design whether it's
through incentives I think is one to to
sort of make them be in control of the
data but also initiate sort of more
liquidity and movement was interesting
for me. Um so I thought it was
interesting. The second one was on just
u consistent thought on just like what
people are doing to make the data more
usable. I just feel like we were so
focused in the world of interoperability
around just liberating the data. Um and
I think I like the pivot we've making in
this sort of a second decade of
interoperability on what do we do with
it and how do we make the data more
usable. Um and we saw we saw that sort
of interspersed in many speakers whether
it's um you know Amy from included
particularly around sort of integration
is innovation type uh catchphrase she
had on how they're combining data
presenting in a way that's usable useful
for them to sort of engage and take
action um I thought was uh was helpful
there and similarly in the the auraing
approach how do they get the data and
how do they actually make it usable and
presentable in a way that was
understandable and and actionable. Um
whether it's the the cardiovascular age
type concept as opposed to a sort of a
nerdy you know of a pulse velocity
metric um or in the example that Vishal
had on just a sort of gamification
modification to sort of do something
with data to make action happen. So I
thought it was interesting um the things
we can learn particularly as we have all
these pledges that are doing the CMS
health tech interpretatory work. We're
going to see more more data more apps
coming in.
The third point was really around value
based care. I think for me um just more
opportunities for us to um I think Iv's
point on speeding up incentives
incentivizing more specific things um
sometimes between like shared savings
and capitations we get sort of a it lots
of things get like sort of stuck under
the wash and so being able to sort of
like change certain behaviors on on um
data as well as more frequent incentives
I think just something for us to keep
thinking about as we continue to give
feedback on payment models as well. So
anyways, those are three themes that
stood out for me.
>> Thank you, Krishna. I'm going to go to
Jay and then Larry.
[Music]
Well, I was uh encouraged to hear during
the wearable session that
these companies are taking into
consideration that when the business
case is made in terms of improved
clinical outcomes for wearables and
digital tools that's needs to be made
available to all populations that it
just can't be self-pay in commercial
populations. It's they've got to be
available to Medicare, Medicare
Advantage, Medicaid plans as well and
Medicaid patients. Otherwise, we're just
going to have a whole new bucket of, you
know, healthc care disparities in terms
of a digital divide. And the second
thing that kind of struck me as being
absent in today's conversation was the
lack of attention to the interaction
between primary care physicians and
specialists in decision making for a
patient. It never came up. It's kind of
okay. We've got this great data for the
specialist to make a decision with the
patient and we've got data for the
primary care to make a decision about
the patient. But I heard very little
about the interaction between the
primary care physician and the
specialist making a a decision shared
about the patient with the patient being
part of that process. I don't know
whether it just didn't come up or was an
oversight or whatever, but I was struck
by the absence of that especially in
today's world with the fragmentation of
primary care which from my perspective
is being driven by GLP-1 inhibitors.
When you've got Weight Watchers, when
you've got him and hers, when you've got
N now into the weight loss and in and
diabetic care business, it's getting
even more fragmented, which means you're
going to have less
interactions between quote primary care
and specialty care. So I think I think
we got to pay attention to that as we
build out, you know, valuebased care
models
not to lose that component of care.
>> Right. Great thoughts, Jay. I'm going to
go next to
Jenny.
>> Um, and after sorry, after Chenny is
Larry. Um, you know, I'll echo a lot of
what everyone said except I have a
couple of additions. The first being
that I'm optimistic after today because
just seeing that
there is a march towards more and more
liquid data that is becoming more and
more interoperable, accessible. You
know, it's today was a positive meeting
in that sense. you know the just having
been in that chair and looking at data
10 years ago in Excel spreadsheets we've
come a long way. Second um I love the
idea of federated identity and I think
that that's one of the things that
imagine the amount of people that look
at clipboards and the amount of staff
that has to interpret that data and
enter it in right just from a pure labor
perspective and operations. So the more
we can do that and the frustration I so
it was really rewarding to see that that
is coming and then understandability
you know a lot of our speakers struck on
that but I did think that it wasn't
nobody sort of brought it to home base
because there is a big gap between data
and how providers and patients
understand the data and what those
insights mean and even though they're
generating those insights I still think
that there's a arbitrage in that
understandability barrier in knowledge
and I I I didn't really sense that
addressed that well except for a couple
of people.
What I did like is that there seems to
be a convergence
where you know historically it was like
healthc care existed in this silo and
retail products existed somewhere else.
There seems to be a convergence where
health care has this sort of patient
consumerf facing data coming out of it
and then uh things like the ring has the
aura has patient data that is moving
into healthcare and so that convergence
of data I feel is sort of a new place in
healthcare right now and it seems to be
sort of moving. What I would have liked
to have seen more of is ideas around
reimbursement and how we reimburse not
just the the accessibility of that data
better but also how do you know there's
being a primary care physician it's like
now you know it's replacing the EMR like
EMR just gave us volumes and volumes of
documentation I had to fill out 10 pages
of documentation
now that's replacing it with now I have
all this data to interpret right and and
I'm
people's sleep record from when they're
sleeping 24/7 and what am I going to do
with that? And so as a family doc
between seeing my 30 patients a day at
15 minutes and filling out my quality
and my AWVs
now I have ring data um that of someone
maybe not sleeping on a Thursday night
and what am I supposed to do with it?
So, I think there's there's got to be
some conversation around how do we
reimburse for the incredible volume of
data that's going to be heading towards
doctors.
>> Okay, Larry, thanks for being patient
with me, Larry.
>> No, no problem. No problem. Um, I also I
think I'm going to have a little chinny,
a little Jay here because I had some
things that I was encouraged with and
some things that I remain disappointed
and and and fearsome about. And
certainly I think we've made tremendous
progress that once
information gets digitalized
we are coming up with better solutions
to integrate it and make it available
and compile it. And there there's been a
lot of progress there.
I still think that the problem I I that
troubles me is the digitalization
period. The point the interface that
both happens at the patient and at the
provider level and getting
healthc care information into digital
format so then it can go on that super
highway.
um where we have an owner ring.
That's that's cool. Okay. But there are
so many apps out there now.
And we heard this over and over again
that that are that are producing
information. They're they're not
integrated.
Um some of them shouldn't be integrated.
Um,
and we're having a and it creates
challenges for us to try to analyze and
and I love the the the story about the
obesity between the reporting it on
claims or picking it up uh from BMI.
Again, BMI a very definite
digitalization of health healthc care
information that you could do something
with. And yet on the on the claim side,
it's it's a morass. There's too much
heterogeneity in what's being done. Um
there's heterogeneity in the abilities
of the providers to provide it. Um and
lack we still lack financial incentives
for anybody to to do it. So I still did
not hear enough of what we need to do at
the patient and the provider interface
to get data digitalized. I was really
blown away by the gamification piece. I
love that. I think we need to study that
more and more about you know how to
continue to motivate people and the
gaming space is a wealth of information
for us on there. Finally, on end on a
positive note,
G um Abe
left me positive. Um I feel like I heard
from him and from his team
a value for our committee. Um I I I
agree with with what they see. I also
was happy to hear that, you know, rapid
cycle innovation is something they're
they're focusing on. So it's a mixed
bag. It was a mixed bag of positives and
negatives, but overall I thought it was
a great day.
>> Thanks, uh, Larry, uh, Josh, and then
Walter.
>> Great. I agree with everybody. I think
this is a really great meeting. Um, I
think, you know, my comments stem from a
few kind of core principles that I'll
highlight. I think the first uh is that
I think we definitely need innovation.
We need markets to work within our
policy and regulatory frameworks, and I
think efforts to explore this are good.
Um that said, kind of my north star, so
to speak, really is thinking about the
public good. You know, what we're
charged with and thinking about what
benefits people who are taxpayers and
beneficiaries in these programs, um
Medicare, Medicaid, and the like. And I
think, um I'll come back to that as I as
I go through here. I think within that,
what I've heard from people today and I
fully agree with is we need system
solutions rather than point solutions.
Um I just say here that there are levels
to this, right? We're talking about
these point data solutions versus
platform data solutions. But if you take
a big step back, I've heard from around
the table and from ourmemes that, you
know, data itself even if it's full of
sense doesn't mean care delivery reform,
reimbursement, etc. There's a bigger
system we're talking about here. So I I
I would hope that, you know, we would
think about that as we um interpret what
we're hearing. And then the third kind
of principle, which is overarching, is
kind of that trade-offs to me are
inherent. Um and so, you know, no doubt
data, more data, more liquid data can
drive better.
No doubt more data requires more time,
more energy, workflows, changes. Not all
of those, in my opinion, are always
better. Um, and more time managing data
means less time elsewhere. In the
context of payment models, more you
know, payment or incentives for data has
to come at a trade-off somewhere if we
want to balance fiscal responsibility
with, you know, access, engagement, and
high quality care. And so I think I mean
I'm not saying anything I think the
committee doesn't recognize but no one
said these things directly but they kept
coming up as I listened to each person
and um I'll just be brief but as I think
through you know what Mark talked about
individualization he held up his cell
phone and looked at talked about apps I
think that's great but we're in some
ways talking about system solutions
right you're talking about payment
models that can have full populations
not bespoke for every single person um
and that's that's a tough thing to to do
you know Amy talked about the need to
kind of solve for use cases and
deliverize has data for jobs to be done.
I agree with that. Um I also think
there's an array of stakeholders that
have multiple jobs to do, whether that's
that person scheduling at the front desk
or the caregiver working with someone
with multiple chronic conditions and and
spans the gamut. So again, trade-offs
there. Kristen talked about federal ID
methods. Really like that idea. I share
Lee's um excitement about that. I also
recognize that the examples given today
um also happen within pretty tightly
regulated, arguably top down systems. Um
TSA being one example of that. So again,
how do you balance that with
individualization?
Trevor talked about innovations in Epic.
I think that's fantastic. Um I think any
strategy that is blank group or company
will do it. We'll fix it leads to this
question of is that how we drive
competition, innovation, and what's best
for the the the patient or the consumer.
Not sure. Michelle mentioned the three
Ps. I like that as very much. He also
hinted at something though which is that
again you know whether you go to the
chain or you tokenize things there's
this question of all of this stuff we do
with data and the payment and the
delivery models around it it should
acrue value to the groups that are
affecting change but ultimately needs to
acrue value back to the taxpayer
Americans and the people in these
programs and so I just want to be very
careful about that right I don't know
that um there are probably different
visions of what solutions and ideal
looks like here across stakeholders and
we should be very mindful of that my my
own personal opinion
Ricky mentioned the not wanting to kind
of drown people under spreadsheets and
mountains of data. I agree mentioned
this pulfay velocity bit. Um that said
we also don't want blackbox solutions,
right? We want transparency and we want
to safeguard people in use of data. So
another trade-off and the last thing
I'll say because I'm getting longwinded
here is you know I really appreciated
Tom Lee and David Kendrick talking about
getting data in front of patients and
physicians. And I have to admit I I'm
still cogitating on this point. But you
know I think the idea of getting data
there compels us to make sure that those
data are real. And so for those
practicing clinicians around the table
or those in the past you you know there
are data that are put in front of you.
You're not quite sure is it
statistically reliable? Is it mine? You
know Lee mentioned you know this levels
to it. You know only 40% of your
patients to get to some higher
percentage. That's really easy to say.
It's much harder to do and I think both
gentlemen referenced that. I think
there's just these trade-offs here and I
just return to that northstar of you
know we need innovation and we need data
but there are bigger system solutions
that we need and I would love to see it
make sure that we acrew value back to
publicly administered programs and the
beneficiaries and the caregivers that
pay into and benefit from it and in that
I don't think trade-offs are a bug of
this system I think they're a feature
and I hope we elevate that. Thanks.
>> Thanks Josh. Uh, Walter, bring us home.
>> Yeah, I know it's a bit past five or
over time, so I'll try to keep my
remarks short. Uh, and actually going
last at its benefits because a lot of
what I uh had in mind has already been
said, so I I won't um repeat uh all
that. Um, I I guess uh I should just say
I kind of came into this public meeting
as a bit of a skeptic. uh and I I'm
sorry to say I I still am a bit of a
skeptic in terms of um exactly uh how we
are going to use data and uh health
information to uh better empower
consumers and support uh and support
providers. You know, maybe I should just
pick up where uh Josh left off in terms
of um how are we going to pay for all
this, right? I I think without that that
um link uh from uh empowering patients
with this data uh to health outcomes. I
I think that's going to be very very
difficult to um uh figure out. Uh we do
have a whole session on um payment
models and benefit designs tomorrow and
so I'm hoping to find answers there. Um,
I'm encouraged by uh an the example that
uh Ricky gave about how there's one
Medicare Advantage plan who's willing to
uh pay for the digital tool that his
company makes uh because they find value
in it, you know, and I I think um
probably uh a canary in the coal mine
will be seeing Medicare Advantage plans
actually start uh paying for some of
these tools um to uh validate that there
is indeed a link to good outcomes. Um I
I am encouraged uh by the uh idea that
we can actually uh turn the enormous
amount of data that we have into more
actionable
uh
um
a tool uh more actionable information at
the point of care. Um I think innov uh
kind of made that point very very well.
Um and uh as did others during during
their uh during our sessions today, uh
the idea that maybe uh there are um
platforms that can sit on top of legacy
platforms uh using AI to really help um
make help providers make better clinical
decisions at the point of care I I think
is really important. Um, and the last
thing I'll say is, uh, I Krishna started
off the PCDT presentation by, um,
listing out a lot of different areas
that patients can be empowered, uh,
through better data. And, uh, one of the
first things he said was patients can be
empowered to make informed decisions
about their choice of health plans and
providers. Now, I think that's probably
the most important choice that uh, a
patient can make about their personal
health care. Um, and I kind of hope that
we would have heard a bit more about
about that uh about how um
solutions are out there to help uh
patients digest the enormous amount of
quality and cost data that's available
to help them make better informed choice
about providers. Um, and and so I think
uh that's just something I'm hoping to
hear a bit more about tomorrow.
>> Thank you, Walter. And then one one last
tangling Chad that occurred to me that I
want to be sure we we get in the minutes
and reflect on is is two at least two
speakers spoke to as we engage patients
with all this rich data and it becomes
more liquid and we start innovating and
we drive value we've got to pay
attention and because we are the PTAC we
talk a lot about how to pay for value
based care but the last mile of that
payment going to the physician has in
general stagnated not changed in nearly
20 years. So we need to be need to be
thoughtful but but advise as CEMI
innovates that they use their their
tools of policy, their waiver power and
build model elements that require or
make mandatory in some fashion the last
mile of payment changes to reflect
alternate payment models and value as
opposed to continuing pay based on based
on volume. So with that I thank my uh
colleagues um incredible
sessions um wonderful discussion and
thank you for all those of you who
listened in. We will be back tomorrow
morning at 9:00 a.m. Eastern time to
start day two. We'll be joined by eight
incredible experts with varying
perspectives. Our day two agenda will
feature two different sessions. The
first will be on data-driven approaches
for enabling patients with chronic
conditions and enhancing secondary
prevention. And the final session will
be covering payment models and benefit
design improvements to enhance patient
empowerment. There will also be an
opportunity for public comments tomorrow
afternoon before the meeting concludes
with the committee discussion. We hope
you will join us then. Thank you. Uh for
now, this meeting is adjourned for the
day. Thank you.
Produced by the US Department of Health
and Human Services.